Status:
COMPLETED
Families With Substance Use and Psychosis: A Pilot Study
Lead Sponsor:
Mclean Hospital
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Psychosis
Substance Use
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The purpose of this study is to develop and evaluate an intervention that adapts Community Reinforcement and Family Training (CRAFT) for families experiencing first episode psychosis and substance use...
Eligibility Criteria
Inclusion
- Ages 18-70.
- Having a relative who:
- Is a patient with early course psychosis (DSM-5 schizophrenia, schizoaffective disorder, schizophreniform, psychosis not otherwise specified (NOS), delusional disorder, brief psychotic disorder, major depression with psychosis, and bipolar disorder with psychosis) with first onset in the past 6 years, and
- Uses tobacco, alcohol, or cannabis in the past 90 days and/or has no apparent immediate interest in abstinence.
- The person(s) who can best describe the client with psychosis.
- At least 4 days per month contact with the client.
- Access to a computer with internet or mobile phone with video conferencing capabilities.
- Ability to provide written informed consent.
- Speak and read English.
Exclusion
- DSM-5 moderate or severe substance use disorder in the past year.
- Lifetime psychotic disorder.
- History of domestic violence with the identified patient (IP).
- Psychiatric, cognitive, or medical impairments that would interfere with the ability to follow through with the treatment plan.
- Inclusion Criteria for Client Relatives:
- Ages 18-35.
- First episode psychosis (FEP) onset in the past 6 years with a DSM-5 diagnosis of affective (bipolar disorder or major depressive disorder with psychotic features) or non-affective psychosis (schizophrenia spectrum disorder).
- a. Used tobacco, alcohol, or cannabis within the past 90 days and/or has no apparent immediate interest in abstinence.
- Ability to provide written informed consent.
- Speak/read English
Key Trial Info
Start Date :
September 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 7 2022
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT04284813
Start Date
September 24 2020
End Date
July 7 2022
Last Update
October 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McLean Hospital
Belmont, Massachusetts, United States, 02478